Herpes simplex virus (HSV) enters and infects most cultured cells. We have found that swine testis cells (ST) produce yields of infectious HSV-1 up to four orders of magnitude lower than those of human embryonic lung (HEL) and HEp-2 cells because of a defect in virus entry. For ST cells, virus (7, 10, 27, 35, 41) . Initial attachment of HSV-1 is to heparan sulfate (HS), a ubiquitous cell surface proteoglycan (24, 34, 42) . A subsequent stable attachment involves binding that is resistant to heparin washing and involves a saturable cell surface receptor(s) that is not HS (7, 17, 18, 21, 26, 27) . Glycoprotein C (gC) and gB bind to HS (13, 33) . At least gD, and perhaps gH, is required for binding to the saturable stable attachment receptor(s) (6, 18, 21) . The molecular interactions of the many viral surface components and cell components during HSV attachment and entry, or the nature of the stable attachment receptor(s), have not been elucidated.
Herpes simplex virus (HSV) is a common human pathogen that causes oral and genital lesions and widespread morbidity and mortality, especially in immunocompromised hosts. In its natural human host, HSV undergoes both lytic and latent infections that may involve multiple tissue types (35) . The virus can infect and replicate in a wide range of cultured cells. Virus entry into cultured cells by fusion with the plasma membrane occurs through a cascade of virus-cell interactions and involves at least two types of binding to trigger efficient penetration at neutral pH (7, 10, 27, 35, 41) . Initial attachment of HSV-1 is to heparan sulfate (HS), a ubiquitous cell surface proteoglycan (24, 34, 42) . A subsequent stable attachment involves binding that is resistant to heparin washing and involves a saturable cell surface receptor(s) that is not HS (7, 17, 18, 21, 26, 27) . Glycoprotein C (gC) and gB bind to HS (13, 33) . At least gD, and perhaps gH, is required for binding to the saturable stable attachment receptor(s) (6, 18, 21) . The molecular interactions of the many viral surface components and cell components during HSV attachment and entry, or the nature of the stable attachment receptor(s), have not been elucidated.
For viruses for which cell receptors have been identified, an important consideration is availability of a cell line that is poorly susceptible to infection. The most elegant studies done to prove a virus receptor and roles of receptors in infection, pathogenesis, and tropism take advantage of a limited range of cell susceptibility and availability of cells that lack a required receptor (2, 3, 11, 25, 29, 31, 36, 39, 43, 44) . For HSV-1, one obstacle to studies of receptors for entry has been lack of a cell line that does not replicate HSV-1 because of a defect in entry. The few characterized cells that are poorly susceptible to this virus, for example, Xenopus oocytes, erythrocytes, and Chinese hamster ovary (CHO) cells, appear to be defective in steps other than entry. More recently, GroC mutant mouse L cells (12) or CHO cells (34) , used to study the role of HS in HSV * Corresponding author.
infection, have been shown to be defective in or produce altered HS. These cells seem to contain components which allow entry and production of virus (12) or immediate-early virus products (34) .
In this report, we establish that swine testis (ST) cells are minimally susceptible to HSV-1 infection because of a defect in virus entry. Moreover, these cells are the first cells characterized to contain functional amounts and types of HS used in attachment but lack a functional, stable non-HS receptor(s) required for the stable attachment(s), which leads to efficient HSV-1 entry. These results define one determinant of HSV-1 cell tropism. Further, they provide a novel and valuable resource for studying binding to multiple receptors during entry of HSV and identifying the nature and function of the stable-attachment non-HS receptor(s) for HSV-1.
MATERIALS AND METHODS
Cells and viruses. The cells used were human embryonic lung (HEL), swine testis (ST), African green monkey kidney (Vero), human larynx epidermoid carcinoma (HEp-2), and swine kidney (SK-6) cells. HEL, HEp-2, and Vero cells are highly susceptible cells commonly used to culture and study HSV-1. All of the cells except Vero cells were grown in 5668 SUBRAMANIAN ET AL.
were used at a multiplicity of infection of 10 or 2 PFU per cell to determine the number of HSV-infected cells.
Determination of virus yields and infectious centers. Monolayers containing approximately 4 x 106 cells in 25-cm2 dishes were infected with viruses for 90 min at 37°C. After removal of the inoculum, monolayers were overlaid with medium 199 containing 2.5% calf serum and incubated at 37°C until the indicated time for harvest. Yields of infectious virus were determined in duplicate on Vero cells by using an overlay of medium 199 containing methylcellulose. Titers included infectious virus from both cells and medium. Infectious centers of HSV-1 were determined by infecting approximately 3 x 106 cells with virus at 0.1 or 2.0 PFU per cell. After 90 min of incubation, the inoculum was removed and residual virus was inactivated with citrate buffer (pH 3.0) (27) . At 3.0 h postinfection, the cells were trypsinized, diluted in medium 199 containing 2.5% calf serum and plated on Vero cells. After the cells had attached, the monolayers were overlaid for 48 h with medium 199 containing methylcellulose to determine the number of infectious centers.
Electron microscopy of infected cells. ST or HEL cells were mock infected or infected with HSV-1 or PRV at 0.01 or 3.0 PFU per cell. Cells were fixed at 10 or 30 h postinfection and processed for thin-section electron microscopy as previously described (7) .
Preparation and binding of purified, radiolabeled virus to cells. Radiolabeled HSV-1 was purified by dextran gradient centrifugation as previously described (9) . Aliquots of 3H-labeled virus that contained 8.9 x 108 PFU/ml and 12,500 cpm/0.10 ml were stored at -80°C. A dose response of virus binding at 4°C was determined as previously described (9 Fig. 4A ) prior to onset of DNA synthesis, cells were infected at 40 PFU per cell and Southern hybridization of DNA from nuclear extracts was performed. At 30 min or 2 h postinfection, the viral inoculum was removed and monolayers were washed three times with PBS to remove the unbound virus. Cells were trypsinized, resuspended in PBS, and pelleted at 200 x g for 5 min before nuclei were isolated and nuclear DNA was extracted as described previously (40) . This procedure eliminates any signal from viral DNA that might be sequestered in cytoplasmic vesicles because of noninfectious endocytosis (10, 35) or virus attached to cell surfaces via HS (27) . Moreover, it examines DNA in the nucleus, where HSV initiates gene expression. To determine DNA from virus replication (see Fig. 4B ), ST or HEL cells were infected at 0.01 PFU per cell for 90 min, the virus inoculum was removed, and the cells were washed and incubated at 37°C for 24 h. Total cellular DNA was isolated by chloroform-phenol extraction and ethanol precipitation, digested with BamHI (Gibco-Bethesda Research Laboratories), separated on a 0.8% agarose gel, and transferred to a nylon filter (Schleicher & Schuell) for hybridization as described elsewhere (37) . Filters were probed with an HSV-1 DNA Sma fragment containing the gD-1 gene that had been radiolabeled by random priming.
Production of virus proteins. Synthesis of virus-specific proteins was determined as previously described (10) , by pulse-radiolabeling of confluent monolayers of Vero, ST, and HEL cells in 24-well dishes. The cells were infected at 37°C with the amounts of virus indicated in the figures and labeled at 4 h and 10 min postinfection for 20 min with [35S]methionine at 20 plCi/ml in methionine-free medium. Cells were washed with cold PBS containing 1.0% glucose and 2.5% calf serum. Cell proteins were solubilized in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) buffer and analyzed on an 8.5% polyacrylamide gel cross-linked with N,N'-diallyl tartardiamide. Total protein was quantitated by the Bio-Rad protein assay, and samples were equalized for SDS-PAGE. The gels were processed with Amplify (Amersham), dried, and exposed to film for fluorography. The major viral capsid proteins (4, 14) for HSV-1 and HSV-2 (large arrows) and for PRV (small arrow) are indicated in Fig. 3 .
Polyethylene glycol (PEG) treatment for HSV-1 infectivity. Confluent monolayers of cells in 30-mm-diameter dishes were infected with HSV-1 at 40 PFU per cell for 1 h at 37°C. The viral inoculum was removed, and the monolayers were exposed to PEG 6000 at 50% (wt/vol). Successive washes were immediately performed with 1:3 and 1:7 dilutions of PEG (10) . Cells were washed with DMEM and overlaid with DMEM containing 8% FBS for 3.5 h. Cells not exposed to PEG were treated similarly in PBS without PEG. For analysis of protein synthesis, at 4.5 h postinfection, the cells were labeled for 30 min with medium that contained [35S]methionine. Cells were washed and solubilized, and proteins were analyzed by SDS-PAGE. To determine yields after PEG treatment, cells were incubated in DMEM and harvested at 10 h postinfection. Cells were detached at 3.0 h postinfection and diluted, and infectiouscenter titers were determined.
Transfection of viral DNA. HSV-1 or PRV genomic DNA was isolated from infected cells as previously described (20 
-50 mM sodium acetate (pH 6.0), 1 -ml fractions were collected and monitored for radioactivity and conductivity. Proteoglycan fractions from Q-Sepharose chromatography were identified by their [35S]radioactivity profiles. Pooled samples of proteoglycans were digested with chondroitin sulfate ABC lyase (100 mIU/ml) in 0.1 M Tris-0.1 M acetate (pH 7.3) for 60 min at 37°C, and digested proteoglycans were analyzed by Q-Sepharose anionexchange chromatography. Fractions containing 35S radioactivity were pooled, dialyzed against H20, and lyophilized.
Characterization of HSPG. HSPG pools for HEL or ST cell fractions were reconstituted in H20 and vacuum dried. Glucosaminoglycans were prepared by treating labeled HSPG at 45°C for 24 h with alkaline borohydride in 1-ml volumes of 0.05 M sodium hydroxide-1.0 M sodium borohydride. Excess borohydride was destroyed by neutralizing the solution with 5.0 M acetic acid. Glucosaminoglycans were differentially cleaved by either heparitinase digestion or nitrous acid treatment. Heparitinase digests were performed identically to chondroitin sulfate ABC lyase digests, except that 5 mIU of enzyme per ml was used. Nitrous acid treatment was performed at low pH. Following treatment, the volumes of the samples were reduced to 250 p.l. An equal volume of 8 M guanidine HCl was added to bring the final concentration of the treated samples to 4 M guanidine HCl. Alkaline borohydride-treated samples were analyzed by chromatography on Superose 6 columns, and both heparitinase-and nitrous acid-treated samples were analyzed by chromatography on Superdex 75 columns. Columns were equilibrated and eluted in 4 M guanidine HCl-50 mM sodium acetate-0.5% Triton X-100 (pH 6.0) at a flow rate of 0.4 ml/min.
Inhibition of sulfation by sodium chlorate. All chlorate experiments were performed in sulfate-free DMEM (GibcoBethesda Research Laboratories). Medium was supplemented with 8% FBS that had been dialyzed for 72 h against buffer containing 150 mM NaCl and 50 mM HEPES (pH 7.4) in distilled, deionized water. Sulfate-free DMEM and serum contained approximately 0.013 mM of free sulfate per ml. HEL or ST cells were replated 16 h prior to infection into 60-mm2 dishes in sulfate-free DMEM that contained the concentrations of sodium chlorate or sodium sulfate indicated in Fig. 7 . Monolayers were infected with HSV-1(F) at 2.0 PFU per cell in sulfate-free PBS containing 1% calf serum and 1% glucose for 90 min, and extracellular virus was inactivated with citrate buffer (pH 3.0) for 2 min (27) . Monolayers were washed twice with PBS and overlaid with 5 ml of sulfate-free DMEM until 10 h postinfection, when cells and virus were harvested. The concentrations of chlorate or sulfate indicated in the figures were maintained throughout infection and overlaying. Virus was released from infected cells by three freeze-thaw cycles, and its titer was determined in duplicate on Vero cells. (Fig. IA) showed that at the low multiplicity of infection typically used to produce maximum virus yields, HSV-1 produced infectious-virus yields on ST cells that were 2 to 4 orders of magnitude lower than those produced on In another approach, HEp-2, ST, and SK-6 cell monolayers were exposed at 10 PFU per cell to an ICP4 null mutant virus that encoded lacZ (5). Cells were subsequently stained with 5-bromo-4-chloro-3-indolyl-,3-D-galactopyranoside (X-Gal) to detect production of ,B-galactosidase. While the entire HEp-2 monolayer stained blue from P-galactosidase activity, less than 0.5% (872 + 22 ST cells and 568 + 16 SK-6 cells) of approximately 3 x 106 cells were blue. We also used a gC null lacZ mutant virus that is capable of producing plaques because gC is not required for replication or spread of HSV-1 (13) . In monolayers exposed to this mutant, the presence of individual blue cells, even at 48 h, indicated that only a few single cells in the population were susceptible to HSV infection. Results of ICP4 and gC null virus infection and counting of infectious centers (Fig. 2B) suggest that the few susceptible cells in the heterogeneous ST cell monolayer likely produce the 103 maximum HSV-1 yields (Fig. 1) . Moreover, the electron microscopy results suggest a defect early in HSV interaction with ST cells. All of these results show that ST cells are poorly susceptible to infection by HSV-1.
RESULTS

Susceptibility of ST and HEL cells to HSV-1 infection. The time course of HSV-1 infection
Appearance of proteins and viral DNA in infected ST and HEL cells. One of the earliest detectable events in HSV-1 replication is production of virus-encoded proteins and shutoff of synthesis of cellular proteins by a protein carried within the virus particle. We examined protein profiles from ST and HEL cells after their exposure to HSV or PRV (Fig. 3A) . At (Fig. 4) . When probed prior to DNA synthesis for DNA from input virus replication at 30 min or 2 h, HSV DNA could be detected in HEL cells but not in ST cells (Fig. 4A) . After replication at 24 h, when abundant DNA appears in HEL cells, HSV DNA was just visible in ST cells at the higher virus input. This signal likely represents replication of HSV in the few (less than 0.5%) susceptible ST cells and demonstrates the sensitivity of the Southern analyses.
Virus binding to ST and HEL cells. Poor susceptibility of ST cells to HSV-1 infection might result from a block in any one of many steps in virus production. Electron microscopy (data not shown), protein synthesis profiles (Fig. 3A) , and Southern blot analyses (Fig. 4) (Fig. SA) . Because HSV entry involves multiple types of binding (7, 18, 21, 27, 35) , the amount of radiolabeled virus that remained bound to cells after selective washing with PBS, heparin, or a high salt concentration was determined (Fig. 5B) . ST cells bound approximately 50% less virus that resisted removal with PBS. For both cell lines, PBS-resistant virus could be removed by heparin while a residual amount of virus could not be removed by heparin. Although less virus attached to ST cells, the twofold reduction in virus binding seemed unlikely to account for the complete absence of DNA from the input virus, viral protein synthesis, or the 2-to 4-order-of-magnitude difference between yields ( Fig. 1 and 2 ) or infectious centers (Fig. 2B) . These results indicate possible differences in the type of, or outcome from, attachment of HSV-1 to ST and HEL cells.
Effects of PEG on virus entry. One explanation for low yields of HSV-1 from ST cells that is consistent with experimental observations (Fig. 1 to 5 numbers of infectious centers. After PEG treatment, ST cells exposed to HSV-1 (Fig. 3B ) produced prominent HSV-1 protein bands and shutoff of cellular protein synthesis. The virus bands were slightly less intense in PEG-treated ST cells, but their intensity increased with a longer incubation time before pulse-labeling (Fig. 3B, lane 9) . Although minor variations in sample loading might contribute to the lower intensity, the slightly lower level of virus proteins also might result from less efficient or later (treatment at 1.5 h postinfection) PEGmediated virus entry than normal virus entry into HEp-2 cells. As also assessed by production of infectious virus ( Fig. 2A) , PEG treatment of ST cells exposed to HSV-1 substantially increased virus yields. Moreover, PEG-mediated cell fusion increased infectious centers on ST cells to 139-fold, compared with a twofold increase for Vero cells (Fig. 2B) Fracton number virus entry. Entry of HSV involves at least two types of attachment that trigger membrane fusion (7, 21, 27) . The virus binds to HS (33, 34, 41) and another, non-HS, stable-attachment receptor(s) (7, 17-19, 21, 27) . Binding of virus to ST cells (Fig. 5) suggested the presence and activity of at least one of these receptors. We examined ST cells for functional HS or a second receptor(s). Since PRV attaches to HS during entry (30, 33) , efficient PRV entry into and infection of ST cells (Fig.  iB, 3A , and 6B) indicated the presence of HS. Moreover, heparin-sensitive HSV-1 binding to ST cells (Fig. SB) also suggested the presence of functional HS. The residual heparinresistant binding (Fig. SB) might result from multivalent attachments of virus glycoproteins to HS or from attachment to a non-HS stable-attachment receptor(s). We tested the hypothesis that ST cells contain functional HS but lack functional amounts of the non-HS stable-attachment receptor.
The amounts, chain lengths, and sulfation levels of HS on ST and HEL cells were determined biochemically by column chromatography of glucosaminoglycans radiolabeled in sulfate or glucosamine. The analyses (Fig. 7) indicated that ST cells contain levels of HS similar to or slightly higher than those in HEL cells (35 and 21%, respectively) . Moreover, the average lengths of glucosaminoglycan chains (73 kDa for HEL cells and 84 kDa for ST cells) and the levels of sulfation incorporated into these chains (47% for HEL cells and 50% for ST cells) were very similar. Thus, ST cells contain HS on the cell surface that is similar in structure to the HS on highly susceptible HEL cells (Fig. 7) and also to that on HEp-2 and Vero cells (27) . From these biochemical analyses of HS, PRV infection, and heparin-sensitive binding of HSV, we conclude that ST cells contain functional amounts and types of HS that should allow initial HSV-1 attachment.
Function of receptors on HEL and ST cells. To further test the hypothesis that ST cells contain functional HS but lack functional non-HS stable-attachment receptors, we determined the effect of undersulfation of HS on infectious yields of HSV from ST and HEL cells. HSV does not bind well to undersulfated HS (12, 24, 28, 34 (12, 28) which suggest that HS is important but not required or sufficient for efficient HSV-1 entry and infection.
DISCUSSION
We showed that ST cells are poorly susceptible to infection by HSV-1 because of a defect in virus entry ( Fig. 1 to 6 ). The low levels of virus found were produced by less than 0.5% of the ST cell population. Heterogeneity of the ST cell line has been confirmed by establishment of nonsusceptible and more highly susceptible swine cell clones (32) . On ST cells, HS is present, allows some virus binding (Fig. 7) , and contributes to the low level of virus produced since undersulfation of HS can eliminate most of this infectious virus ( Fig. 8 and Table 1 ). ST cells seem to lack a functional non-HS cell surface component that mediates stable attachment and penetration for efficient entry of HSV. Virus penetration and subsequent replication can be induced by cell surface treatment with PEG ( Fig. 2 and  3 ). Since HSV-1 replication also occurs in cells when virus DNA is transfected (Fig. 6 ), ST cells are suitable for replication of HSV-1 if the virus or its genome can successfully enter. Poor susceptibility to HSV-1 infection also seems to occur with other swine cell lines ( Fig. 2B; 32 ) and extends to poor susceptibility to HSV-2 ( Fig. 3A; 38) . These findings are consistent with a model of neutral-pH entry of HSV by several phases of attachment in a cascade of virus-cell interactions (7, 27, 35) and with the presence of a non-HS receptor that is required for HSV-1 penetration (7, 18, 21, 27, 28, 35) . Characterization of the defect in entry into ST cells establishes a critical and novel cell line for isolation and study of the HSV stable-attachment receptor(s).
Poor susceptibility of ST cells to HSV-1, the presence of functional HS, and the absence of a functional stable-attachment receptor(s) are consistent with at least two types of attachment required for efficient HSV-1 entry into susceptible cells (7, 21, 27) . Initial attachment to HS can occur on ST cells and is likely responsible for a great part of the virus binding observed. However, lack of penetration, as assayed by virus protein synthesis (Fig. 3) and Southern blot analysis (Fig. 4) HSV-1 neutral-pH entry through a cascade of virus-cell interactions that trigger cell surface fusion (7, 35, 41) is consistent with the presence of at least two types of receptors on susceptible cells, such as HEL, HEp-2, and Vero cells (18, 21, 27) , but lack of a critical stable-attachment receptor(s) on ST cells. Susceptibilities of other human and swine cells lines (32, 37) and of humans (15, 16) or infant pigs (38) to HSV and PRV indicate that tropism of these alphaherpesviruses for cultured ST and HEL cells may represent species tropism. It has been well established that PRV, an alphaherpesvirus native to swine that is very similar to HSV, does not infect or replicate in humans (15, 16) . We have shown (37) that PRV does not replicate well in most human cells, particularly primary cells, because of a post-entry defect in regulation of immediate-early gene expression. We have also found that under conditions in which PRV caused the death of infant pigs in several days, the pigs survived with no evidence of HSV replication or cytopathic effects (38) . These studies (this work; 15, 16, 32, 37, 38) suggest that the susceptibilities of cultured cells are likely relevant to natural animal tropism of these viruses. The ubiquity of HSV infection of a broad range of animal cells (35) indicates that either the required stable-attachment receptor(s) is also quite ubiquitous on cells or that there are a variety of cell surface proteins that can be used to mediate stable attachment and entry. The variety of host tissues that HSV infects suggests that both of these possibilities may occur. Further understanding of HSV interaction with poorly susceptible ST cells and use of these cells to identify the human gene product that increases susceptibility provide exciting developments in understanding of HSV entry, tropism, and pathogenesis.
